These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11556843)

  • 1. DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2.
    Narayan S; Jaiswal AS; Multani AS; Pathak S
    Br J Cancer; 2001 Sep; 85(6):898-901. PubMed ID: 11556843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth.
    Bhonde MR; Hanski ML; Notter M; Gillissen BF; Daniel PT; Zeitz M; Hanski C
    Oncogene; 2006 Jan; 25(2):165-75. PubMed ID: 16170360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells.
    Zhang Y; Cao EH; Qin JF
    Eur J Pharmacol; 2005 May; 516(1):1-9. PubMed ID: 15904916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons.
    Zhang P; Furukawa K; Opresko PL; Xu X; Bohr VA; Mattson MP
    J Neurochem; 2006 Apr; 97(2):567-81. PubMed ID: 16539655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro binding of p53 and telomeric repeat factor 2].
    Li L; Zhang B; Zou WZ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):88-91. PubMed ID: 15842803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.
    Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P
    Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant telomerase RNAs induce DNA damage and apoptosis via the TRF2-ATM pathway in telomerase-overexpressing primary fibroblasts.
    Mahalingam D; Tay LL; Tan WH; Chai JH; Wang X
    FEBS J; 2011 Oct; 278(19):3724-38. PubMed ID: 21824286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells.
    Shin KH; Tannyhill RJ; Liu X; Park NH
    Oncogene; 1996 Mar; 12(5):1089-96. PubMed ID: 8649801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
    Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
    Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
    Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection.
    Nagasawa H; Keng P; Maki C; Yu Y; Little JB
    Cancer Res; 1998 May; 58(9):2036-41. PubMed ID: 9581850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms.
    Li CY; Huang WF; Wang QL; Wang F; Cai E; Hu B; Du JC; Wang J; Chen R; Cai XJ; Feng J; Li HH
    Asian Pac J Cancer Prev; 2012; 13(8):3757-61. PubMed ID: 23098467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.
    Jaks V; Jõers A; Kristjuhan A; Maimets T
    Oncogene; 2001 Mar; 20(10):1212-9. PubMed ID: 11313865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate.
    Joseph J; Wajapeyee N; Somasundaram K
    Int J Cancer; 2005 May; 115(1):11-8. PubMed ID: 15688418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.